Octreotide acetate combined with somatostatin upregulates miR-1291 and downregulates miR-331-3p in patients with cirrhosis and upper gastrointestinal bleeding

CONCLUSION: OA + SS therapy is safe and effective for the treatment of patients with cirrhosis and UGIB.PMID:34540125 | PMC:PMC8430138

Source: American Journal of Translational Research - September 20, 2021 Category: Research Authors: Xiaodong Liu Xiaohui Guo Hu Zhou Source Type: research